Clinical Trials Directory

Trials / Completed

CompletedNCT05075096

Long Term Outcome in ICU Treated COVID-19: New Chronic Diseases

Status
Completed
Phase
Study type
Observational
Enrollment
60,000 (actual)
Sponsor
Uppsala University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Additional chronic diseases one year after intensive care unit (ICU) admission with Coronavirus disease 2019 (COVID-19) will be assessed in comparison to two control cohorts. The ICU population comprises all Swedish ICU patients with COVID-19 with at least one year of follow up. The hospital admitted cohort comprises four hospital admitted patients with COVID-19 per ICU patient, matched on age, legal gender and region. The general population controls are matched to the ICU patients in a one to four fashion on age, legal gender and region. ICU patients are identified in the Swedish intensive care registry. The hospital admitted patients are identified in the national patient registry and the population controls are identified in the population registry. Data on comorbidity, medications and death are provided from the National board of health and welfare.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention.No intervention observational study.

Timeline

Start date
2021-10-15
Primary completion
2021-11-15
Completion
2021-11-15
First posted
2021-10-12
Last updated
2022-05-24

Locations

1 site across 1 country: Sweden

Source: ClinicalTrials.gov record NCT05075096. Inclusion in this directory is not an endorsement.